Orsight Pharma

Company Overview

Snapshot

Founded in October 2023 by Mariana Truman, Orsight Pharma operates with 1–10 employees. The company has raised $2.1M across two funding rounds, with NGT HealthCare II as an investor. In May 2024, Orsight Pharma secured a grant from the Israel Innovation Authority.

Business overview

Orsight Pharma is a Health Tech & Life Sciences company focused on Pharma & Medical Biotechnology, specifically in Drugs Discovery & Development. The company is developing a breakthrough small molecule treatment for Neovascular Age-Related Macular Degeneration, aiming to preserve vision and prevent blindness through a novel VEGF-independent mechanism. This drug is designed to benefit patients unresponsive to existing therapies and has the potential to enhance visual outcomes when used in combination with current treatments.

Company Intelligence Q&A

When was Orsight Pharma founded?

Orsight Pharma was founded in October 2023.

Who is a co-founder of Orsight Pharma?

Mariana Truman is a co-founder and CTO of Orsight Pharma.

What is Orsight Pharma's primary focus?

Orsight Pharma focuses on developing a small molecule treatment for Neovascular Age-Related Macular Degeneration to preserve vision and prevent blindness.

What is Orsight Pharma's employee count?

Orsight Pharma has 1–10 employees.

What was a recent non-equity funding event for Orsight Pharma?

In May 2024, Orsight Pharma secured a grant from the Israel Innovation Authority.